首页>
外国专利>
AGENT FOR INHIBITION OF ANGIOGENESIS OR MESENCHYMAL-TYPE OR AMOEBOID-TYPE INVASION OF CANCER CELL
AGENT FOR INHIBITION OF ANGIOGENESIS OR MESENCHYMAL-TYPE OR AMOEBOID-TYPE INVASION OF CANCER CELL
展开▼
机译:抑制血管生成,间质型或变形型侵袭性癌细胞的药剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
Disclosed is an agent for inhibiting angiogenesis or mesenchymal-type or amoeboid-type invasion of a cancer cell. The agent comprises, as an active ingredient, a polypeptide comprising an amino acid sequence depicted in SEQ ID NO:1 or 3 or an analogue thereof or a polynucleotide encoding the polypeptide or the analogue. Also disclosed is a method for treatment of a disease for which the inhibition of angiogenesis or the inhibition of mesenchymal-type or amoeboid-type cancer invasion or metastasis is effective. The method comprises the step of administering the peptide, the analogue or the polynucleotide to a patient. Further disclosed is use of the peptide, the analogue or the polynucleotide for the production of an agent for inhibiting angiogenesis or mesenchymal-type or amoeboid-type invasion of a cancer cell.
展开▼
机译:公开了一种用于抑制癌细胞的血管生成或间充质型或变形虫型侵袭的药剂。该试剂包含作为活性成分的,包含SEQ ID NO:1或3所示的氨基酸序列的多肽或其类似物,或编码该多肽或类似物的多核苷酸。还公开了一种治疗疾病的方法,对于该疾病,抑制血管生成或抑制间充质型或类阿米巴型癌症的侵袭或转移是有效的。该方法包括将肽,类似物或多核苷酸施用于患者的步骤。进一步公开了所述肽,类似物或多核苷酸在生产用于抑制癌细胞的血管生成或间充质型或类阿米巴型侵袭的试剂中的用途。
展开▼